LPL Financial’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.4M Buy
295,687
+34,854
+13% +$7.21M 0.02% 833
2025
Q4
$53.9M Buy
260,833
+60,187
+30% +$12M 0.01% 839
2025
Q3
$36M Buy
200,646
+6,873
+4% +$1.17M 0.01% 1003
2025
Q2
$31.3M Buy
193,773
+9,960
+5% +$1.59M 0.01% 999
2025
Q1
$31.3M Sell
183,813
-3,466
-2% -$602K 0.01% 901
2024
Q4
$31.1M Buy
187,279
+10,161
+6% +$1.74M 0.01% 861
2024
Q3
$30.5M Sell
177,118
-22,237
-11% -$3.68M 0.01% 832
2024
Q2
$30.7M Sell
199,355
-51,320
-20% -$7.7M 0.02% 774
2024
Q1
$38.5M Buy
250,675
+77,701
+45% +$11.8M 0.02% 643
2023
Q4
$27.3M Sell
172,974
-10,677
-6% -$1.53M 0.02% 740
2023
Q3
$26.9M Sell
183,651
-13,110
-7% -$2M 0.02% 682
2023
Q2
$30.1M Buy
196,761
+5,264
+3% +$821K 0.02% 621
2023
Q1
$29.7M Buy
191,497
+333
+0.2% +$52.3K 0.02% 594
2022
Q4
$29.5M Buy
191,164
+9,848
+5% +$1.45M 0.03% 546
2022
Q3
$23.9M Sell
181,316
-6,310
-3% -$885K 0.02% 573
2022
Q2
$25.4M Sell
187,626
-20,312
-10% -$2.8M 0.02% 552
2022
Q1
$31M Sell
207,938
-57,520
-22% -$8.51M 0.03% 496
2021
Q4
$43M Sell
265,458
-20,474
-7% -$3.31M 0.04% 399
2021
Q3
$47.5M Sell
285,932
-25,790
-8% -$4.41M 0.04% 354
2021
Q2
$53.8M Sell
311,722
-21,268
-6% -$3.51M 0.05% 316
2021
Q1
$53.4M Sell
332,990
-71,832
-18% -$12.3M 0.06% 284
2020
Q4
$68M Buy
404,822
+39,342
+11% +$6.38M 0.09% 216
2020
Q3
$57.5M Buy
365,480
+20,148
+6% +$3.29M 0.09% 207
2020
Q2
$57.9M Buy
345,332
+121,719
+54% +$19.1M 0.1% 186
2020
Q1
$29.3M Buy
223,613
+34,232
+18% +$4.88M 0.06% 247
2019
Q4
$28.2M Buy
189,381
+4,506
+2% +$619K 0.05% 291
2019
Q3
$22.9M Sell
184,875
-23,641
-11% -$3.15M 0.05% 302
2019
Q2
$29.4M Buy
208,516
+14,543
+7% +$2.01M 0.06% 256
2019
Q1
$29.3M Buy
193,973
+14,138
+8% +$2.03M 0.07% 252
2018
Q4
$22.3M Buy
179,835
+3,944
+2% +$539K 0.06% 267
2018
Q3
$27.9M Buy
175,891
+43,290
+33% +$6.55M 0.07% 240
2018
Q2
$18.6M Buy
132,601
+24,824
+23% +$3.41M 0.05% 299
2018
Q1
$14.3M Buy
107,777
+7,646
+8% +$1.04M 0.04% 343
2017
Q4
$12.5M Sell
100,131
-5,872
-6% -$725K 0.04% 363
2017
Q3
$13.1M Buy
106,003
+2,385
+2% +$282K 0.05% 308
2017
Q2
$11.8M Sell
103,618
-1,339
-1% -$144K 0.04% 324
2017
Q1
$10.9M Sell
104,957
-3,356
-3% -$336K 0.07% 222
2016
Q4
$9.97M Buy
108,313
+15,515
+17% +$1.45M 0.08% 216
2016
Q3
$9.17M Sell
92,798
-16,563
-15% -$1.63M 0.09% 207
2016
Q2
$10.1M Sell
109,361
-162,698
-60% -$14.9M 0.09% 187
2016
Q1
$24.7M Sell
272,059
-330,934
-55% -$29.2M 0.07% 234
2015
Q4
$66.3M Buy
602,993
+281,223
+87% +$30.3M 0.18% 113
2015
Q3
$33.6M Sell
321,770
-22,479
-7% -$2.67M 0.19% 116
2015
Q2
$42.5M Buy
344,249
+12,839
+4% +$1.55M 0.22% 96
2015
Q1
$38.8M Buy
331,410
+69,437
+27% +$7.85M 0.2% 100
2014
Q4
$26.7M Buy
261,973
+34,503
+15% +$3.37M 0.15% 142
2014
Q3
$20.6M Buy
227,470
+12,814
+6% +$1.11M 0.12% 164
2014
Q2
$17.7M Sell
214,656
-32,448
-13% -$2.48M 0.1% 179
2014
Q1
$18.9M Sell
247,104
-25,411
-9% -$1.98M 0.12% 168
2013
Q4
$18.9M Buy
272,515
+25,355
+10% +$1.66M 0.12% 165
2013
Q3
$15.5M Buy
247,160
+82,084
+50% +$5.19M 0.1% 179
2013
Q2
$9.61M Buy
+165,076
New +$9.43M 0.07% 239

Other funds holding FBT

LPL Financial's FBT Position: Q1 2026 in Review

LPL Financial increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 13% in Q1 2026, buying an estimated $7.21M and bringing the position to 295,687 shares worth $59.4M. The position accounts for 0.02% of the portfolio, ranked #833.

LPL Financial first reported a position in FBT in Q2 2013 and has held it in 52 quarters since. The position peaked at $68M in Q4 2020. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • LPL Financial held 295,687 shares of First Trust NYSE Arca Biotechnology Index Fund worth $59.4M as of Q1 2026.
  • LPL Financial bought 34,854 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $7.21M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of LPL Financial's portfolio in Q1 2026, its #833 holding.
  • LPL Financial first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 52 quarters since.
  • LPL Financial's First Trust NYSE Arca Biotechnology Index Fund position peaked at $68M in Q4 2020.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.